Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

New COPD Candidates Could Get Hung Up On Safety Concerns

Jan 28 2013

• By Bridget Silverman

Related Content

Boehringer Ingelheim’s Me-Too Petition Against Generic <em>Spiriva</em>

Nov 26 2012

GSK/Theravance Breathing Easy: Once-Daily COPD Combo Expected To Meet Regulatory Standards

Jul 09 2012

FDA Supersizes Its Order For LABA Safety Studies

Apr 15 2011

Novartis Once-Daily COPD Combo Safe, Effective And Ready For Filing – Everywhere But In The U.S.

Sep 10 2012

Related Companies

GSK plc

Innoviva, Inc.

Boehringer Ingelheim GmbH

Novartis AG

Forest Laboratories, Inc.

Additional Topics

Regulation BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window